Sclerotherapy of face and oral cavity low flow vascular malformations: our experience


      We have reviewed our experience (15 patients during the period 2008–2012) in the treatment of low flow vascular malformations (LFVMs) of the face and oral cavity with polidocanol foam sclerotherapy. They were diagnosed clinically and with the help of Doppler ultrasound and magnetic resonance imaging. The maximum dose recommended for each session was 20 mg/day and the minimum interval between sessions was 4 weeks. Embolisation was repeated as many times as needed until the size of the lesions and the symptoms had been reduced sufficiently. Patients were followed up 1, 6, and 12 months after treatment had finished, and the size of the lesions was assessed objectively.
      The 8 men and 7 women were aged between 18 and 71 (mean 44) years. The lesions had reduced and symptoms had improved in all cases. During the follow-up period, one patient relapsed and developed further symptoms. The pain and postoperative inflammation were successfully controlled with an analgesic and an anti-inflammatory drug. There was only one complication (superficial necrosis), which healed completely by second intention.
      Direct puncture and sclerosis with polidocanol foam are an effective treatment for LFVM of the face and oral cavity.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Yamaki T.
        • Nozaki M.
        • Fujiwara O.
        • Yoshida E.
        Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face.
        Dermatol Surg. 2002; 28: 619-622
        • Gibson K.D.
        • Ferris B.L.
        • Pepper D.
        Foam sclerotherapy for the treatment of superficial venous insufficiency.
        Surg Clin North Am. 2007; 87: 1285-1295
        • Górriz Gomes E.
        • Carreira Villamor J.M.
        • Reyes Perez R.
        Percutaneous treatment of peripheral vascular malformations (in Spanish).
        Rev Clin Esp. 1998; 198: 565-570
        • Górriz Gómez E.
        • Carreira Villamor J.M.
        Percutaneous treatment of peripheral vascular malformations with a mixture of polidocanol and CO2. Initial experience (in Spanish).
        Radiologia. 2008; 50: 424-429
        • Tessari L.
        • Cavezzi A.
        • Frullini A.
        Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
        Dermatol Surg. 2001; 27: 58-60
        • Rehman K.U.
        • Sittampalam G.
        • McCafferty I.
        • Monaghan A.
        The use of foam sclerotherapy for the treatment of head and neck vascular malformations.
        Br J Oral Maxillofac Surg. 2009; 47: 631-632
        • Blaise S.
        • Charavin-Cocuzza M.
        • Riom H.
        Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.
        Eur J Vasc Endovasc Surg. 2011; 41: 412-417
        • Cabrera J.
        • Redondo P.
        Sclerosing treatment of vascular malformations (in Spanish).
        An Sist Sanit Navar. 2004; 27: 117-126
        • Cabrera J.
        • Cabrera Jr., J.
        • Garcia-Olmedo M.A.
        • Redondo P.
        Treatment of venous malformations with sclerosant in microfoam form.
        Arch Dermatol. 2003; 139: 1409-1416
        • Legiehn G.M.
        • Heran M.K.
        Venous malformations: classification, development, diagnosis, and interventional radiologic management.
        Radiol Clin North Am. 2008; 46: 545-597
        • Spence J.
        • Krings T.
        • terBrugge K.G.
        • da Costa L.B.
        • Agid R.
        Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results.
        AJNR Am J Neuroradiol. 2010; 31: 955-960
        • Han M.H.
        • Seong S.O.
        • Kim H.D.
        • Chang K.H.
        • Yeon K.M.
        • Han M.C.
        Craniofacial arteriovenous malformation: preoperative embolization with direct puncture and injection of n-butyl cyanoacrylate.
        Radiology. 1999; 211: 661-666
        • Gloviczki P.
        • Duncan A.
        • Kalra M.
        Vascular malformations: an update.
        Perspect Vasc Surg Endovasc Ther. 2009; 21: 133-148
        • Mol W.
        • Furukawa H.
        • Sasaki S.
        Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol, and OK-432 using an in vitro model.
        Dermatol Surg. 2007; 33: 1452-1459
        • Alòs J.
        • Carreño P.
        • López J.A.
        • Estadella B.
        • Serra-Prat M.
        • Marinel-Lo J.
        Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial.
        Eur J Vasc Endovasc Surg. 2006; 31: 101-107
        • Hamel-Desnos C.
        • Desnos P.
        • Wollmann J.C.
        • Ouvry P.
        • Mako S.
        • Allaert F.A.
        Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
        Dermatol Surg. 2003; 29: 1170-1175
        • Jia X.
        • Mowatt G.
        • Burr J.M.
        • Cassar K.
        • Cook J.
        • Fraser C.
        Systematic review of foam sclerotherapy for varicose veins.
        Br J Surg. 2007; 94: 925-936
        • Berenguer B.
        • Burrows P.E.
        • Zurakowski D.
        • Mulliken J.B.
        Sclerotherapy of craniofacial venous malformations: complications and results.
        Plast Reconstr Surg. 1999; 104: 1-15
        • Lee I.H.
        • Kim K.H.
        • Jeon P.
        Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results.
        Korean J Radiol. 2009; 10: 269-276
        • Kohout M.P.
        • Hansen M.
        • Pribaz J.J.
        • Mulliken J.B.
        Arteriovenous malformations of the head and neck: natural history and management.
        Plast Reconstr Surg. 1998; 102: 643-654
        • Breu F.X.
        • Guggenbichler S.
        European consensus meeting on foam sclerotherapy. April 4–6 2003, Tegernsee, Germany.
        Dermatol Surg. 2004; 30: 709-717